About: Insulin Aspart     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : owl:Class, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
rdfs:label
  • Insulin Aspart
rdfs:subClassOf
Concept_In_Subset
Semantic_Type
  • Pharmacologic Substance
Preferred_Name
  • Insulin Aspart
UMLS_CUI
  • C0123677
CAS_Registry
  • 116094-23-6
FDA_UNII_Code
  • D933668QVX
Contributing_Source
  • FDA
PDQ_Open_Trial_Search_ID
  • 561306
PDQ_Closed_Trial_Search_ID
  • 561306
Chemical_Formula
  • C256H381N65O79S6
Legacy_Concept_Name
  • Insulin_Aspart_Recombinant
FULL_SYN
  • INSULIN ASPARTPTFDAD933668QVX
  • Insulin AspartPTNCI
  • Insulin Aspart RecombinantSYNCI
  • NovologBRNCI
DEFINITION
  • A recombinant human insulin analog with rapid-acting, blood glucose-lowering activity. Insulin aspart, acting faster than regular human insulin, regulates glucose metabolism by binding to insulin receptors on muscle and fat cells, thereby facilitating the cellular uptake of glucose. This lowers blood glucose levels. At the same time, insulin aspart inhibits the liver's conversion of stored glycogen into glucose, which also contributes to lower blood glucose levels. Insulin aspart also inhibits lipolysis in adipose tissue, inhibits proteolysis, and enhances protein synthesis. (NCI05)NCI
code
  • C47563
sameAs
is sameAs of
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 46 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software